then fda based on uspto decision, recommended / requested / processed marine, anchor, reduce it trials
?
FDA did not do anything based on USPTO ...FDA does not have any role in the case … does not deal with the patents other than registers in the Orange Book based on Amarin request (but without to check the "patentability" … it is a simple an administrative task).